Jonas Rahm

Papers

Total Citations

H-Index

About

Jonas Rahm is a leading researcher in the field of pancreatic cancer biology, with a primary focus on developing and applying organoid technology for personalized medicine. His most-cited work, "Organoid technology for personalized pancreatic cancer therapy" (2021, 30 citations), addresses the urgent need for more effective preclinical models for pancreatic ductal adenocarcinoma—the deadliest major cancer, with a five-year survival rate below 10%. Rahm’s major contribution lies in demonstrating how patient-derived organoids can recapitulate tumor heterogeneity and drug responses, offering a powerful platform for tailoring therapies to individual patients. This work directly confronts the stagnant survival statistics and poor response rates that have plagued pancreatic cancer treatment for decades. By bridging the gap between basic cancer biology and clinical application, Rahm’s research has the potential to transform therapeutic strategies for one of oncology’s most challenging diseases. His innovative use of organoid models positions him at the forefront of precision oncology, where his findings are already informing next-generation drug screening and personalized treatment protocols.